Immune checkpoint inhibitors and their impact on liver enzymes and attenuation

BACKGROUND: Immune related adverse events impacting the liver are common from immune checkpoint inhibitor (ICI) therapy; however, there is little data regarding the subclinical impact of ICIs on liver inflammation. The study aims to determine whether ICI therapy affects liver attenuation and liver e...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Benjamin C., Lee, Aaron X. T., Ye, Fei, Turker, Isik, Johnson, Douglas B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487144/
https://www.ncbi.nlm.nih.gov/pubmed/36127638
http://dx.doi.org/10.1186/s12885-022-10090-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487144/
https://www.ncbi.nlm.nih.gov/pubmed/36127638
http://dx.doi.org/10.1186/s12885-022-10090-9

Ejemplares similares